Novonesis Balance Sheet Health

Financial Health criteria checks 5/6

Novonesis has a total shareholder equity of €11.0B and total debt of €2.0B, which brings its debt-to-equity ratio to 18.1%. Its total assets and total liabilities are €15.3B and €4.2B respectively. Novonesis's EBIT is €525.0M making its interest coverage ratio 15.7. It has cash and short-term investments of €260.8M.

Key information

18.1%

Debt to equity ratio

€1.99b

Debt

Interest coverage ratio15.7x
Cash€260.80m
Equity€11.01b
Total liabilities€4.25b
Total assets€15.25b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: NZM's short term assets (€1.8B) exceed its short term liabilities (€1.6B).

Long Term Liabilities: NZM's short term assets (€1.8B) do not cover its long term liabilities (€2.6B).


Debt to Equity History and Analysis

Debt Level: NZM's net debt to equity ratio (15.7%) is considered satisfactory.

Reducing Debt: NZM's debt to equity ratio has reduced from 36.2% to 18.1% over the past 5 years.

Debt Coverage: NZM's debt is well covered by operating cash flow (44.8%).

Interest Coverage: NZM's interest payments on its debt are well covered by EBIT (15.7x coverage).


Balance Sheet


Discover healthy companies